Original Article

Pediatric to adult rheumatology transition: Success rates, influencing factors, and evolving diagnoses and treatments

Volume 39 · Issue 4 · December 2024 Publish Date: December 31, 2024
Full Text PDF HTML
DOI
Tuba Demirci Yıldırım ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
Rana İşgüder ORCID
Department of Pediatrics, Division of Pediatric Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
Ezgi Karaçura ORCID
Department of Internal Medicine, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
Yeşim Erez ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
Balahan Makay ORCID
Department of Pediatrics, Division of Pediatric Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
Fatoş Önen ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
Şevket Erbil Ünsal ORCID
Department of Pediatrics, Division of Pediatric Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
İsmail Sarı ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye image/svg+xml
Tuba Demirci Yıldırım, Rana İşgüder, Ezgi Karaçura, Yeşim Erez, Balahan Makay, Fatoş Önen, … İsmail Sarı. (2024). Pediatric to adult rheumatology transition: Success rates, influencing factors, and evolving diagnoses and treatments. Archives of Rheumatology, 39(4), 662–669. https://doi.org/10.46497/ArchRheumatol.2024.10749
Full Text PDF HTML

Abstract

Objectives: This study aimed to evaluate the rate of successful transitions, identify factors associated with early versus late transitions, and diagnosis and treatment changes after transition into adult rheumatology.

Patients and methods: In this retrospective study, patients with childhood-onset rheumatic diseases who transitioned from pediatric to adult rheumatology care between January 2013 and January 2023 were screened for a successful transition. Successful transitions were defined as maintaining annual visits to the adult rheumatology clinic after transition. Early transition was defined as less than three months between the last pediatric and first adult rheumatology visits.

Results: Out of 2,552 referred patients, 210 (8.2%) patients (117 females, 93 males; mean age: 25.2±5.6 years; range, 18 to 44 years) transitioned successfully. Juvenile idiopathic arthritis and familial Mediterranean fever were the most prevalent rheumatic diseases. The median transition time was four months (interquartile range, 1 to 13 months) in patients with successful transition, and the early transition rate was 46.7%. Receiving biologic disease-modifying antirheumatic drugs was found to be associated with early transition (28.6% vs. 17.0%, p=0.040), and higher education levels and familial Mediterranean fever diagnosis were found to be associated with late transition. The treatment was changed for about half of the patients after transition to adult rheumatology. Patients with juvenile idiopathic arthritis were reclassified in 25 (31.6%) patients as rheumatoid arthritis, in 22 (27.8%) patients as ankylosing spondylitis, in 20 (25.3%) patients as nonradiographic axial spondyloarthritis, and in eight (10.1%) patients as psoriatic arthritis.

Conclusion: A successful transition to adult rheumatology is essential for adolescents and young adults with childhood-onset rheumatic diseases. The successful transition rate in this study was relatively low, highlighting the need for standardized transition programs.

Similar Articles

Article Info
Published In
Journal Archives of Rheumatology
Volume / Issue Volume 39 · Issue 4 · December 2024
Pages 662-669
History
Published Online December 31, 2024
License
Affiliations
1
Tuba Demirci Yıldırım ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
2
Rana İşgüder ORCID
Department of Pediatrics, Division of Pediatric Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
3
Ezgi Karaçura ORCID
Department of Internal Medicine, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
4
Yeşim Erez ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
5
Balahan Makay ORCID
Department of Pediatrics, Division of Pediatric Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
6
Fatoş Önen ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
7
Şevket Erbil Ünsal ORCID
Department of Pediatrics, Division of Pediatric Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
8
İsmail Sarı ORCID
Department of Internal Medicine, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
Cite this Article
Tuba Demirci Yıldırım, Rana İşgüder, Ezgi Karaçura, Yeşim Erez, Balahan Makay, Fatoş Önen, … İsmail Sarı. (2024). Pediatric to adult rheumatology transition: Success rates, influencing factors, and evolving diagnoses and treatments. Archives of Rheumatology, 39(4), 662–669. https://doi.org/10.46497/ArchRheumatol.2024.10749
Share
Outlines